<?xml version="1.0" encoding="UTF-8" standalone="yes"?><drugRecordsOutput><serviceExecutionTime>325</serviceExecutionTime><Drug id="84827"><DrugName>human immunoglobulin (pH4, freeze-dried, immunoglobulin G deficiency/autoimmune diseases), Guangdong Weilun Biological Products</DrugName><DrugSynonyms><Name><Value>human immunoglobulin (pH4, freeze-dried, immunoglobulin G deficiency/autoimmune diseases), Guangdong Weilun Biological Products</Value></Name></DrugSynonyms><CompanyOriginator id="1079335">Guangdong Weilun Biological Products Co Ltd</CompanyOriginator><CompaniesPrimary><Company id="1079335">Guangdong Weilun Biological Products Co Ltd</Company></CompaniesPrimary><CrossReferences><SourceEntity id="1079335" type="Company"><TargetEntity id="5038071977" type="organizationId">Guang Dong Wellen Biological Pharmaceutical Co Ltd</TargetEntity></SourceEntity><SourceEntity id="1133" type="ciIndication"><TargetEntity id="10043561" type="MEDDRA"/><TargetEntity id="D011697" type="MeSH"/><TargetEntity id="-241656606" type="omicsDisease"/><TargetEntity id="1491" type="siCondition"/></SourceEntity><SourceEntity id="2511" type="ciIndication"><TargetEntity id="D80.3" type="ICD10"/><TargetEntity id="D017099" type="MeSH"/></SourceEntity><SourceEntity id="36" type="ciIndication"><TargetEntity id="10061664" type="MEDDRA"/><TargetEntity id="D001327" type="MeSH"/><TargetEntity id="-2072222280" type="omicsDisease"/><TargetEntity id="729" type="siCondition"/></SourceEntity><SourceEntity id="780" type="ciIndication"><TargetEntity id="M30.3" type="ICD10"/><TargetEntity id="10023320" type="MEDDRA"/><TargetEntity id="D009080" type="MeSH"/><TargetEntity id="2331" type="ORPHANET"/><TargetEntity id="-1954143291" type="omicsDisease"/><TargetEntity id="1571" type="siCondition"/></SourceEntity></CrossReferences><PhaseHighest id="L">Launched</PhaseHighest><PhaseHighestDetailed><FirstLaunched>Autoimmune disease - China - Dec-1999</FirstLaunched><FirstLaunched>Immunoglobulin G deficiency - China - Dec-1999</FirstLaunched><FirstLaunched>Kawasaki disease - China - Dec-1999</FirstLaunched><FirstLaunched>Thrombocytopenic purpura - China - Dec-1999</FirstLaunched></PhaseHighestDetailed><IndicationsPrimary><Indication id="1133">Thrombocytopenic purpura</Indication><Indication id="2511">Immunoglobulin G deficiency</Indication><Indication id="36">Autoimmune disease</Indication><Indication id="780">Kawasaki disease</Indication></IndicationsPrimary><ActionsPrimary><Action id="5731">Immunoglobulin agonist</Action></ActionsPrimary><Technologies><Technology id="582">Antibody polyclonal</Technology><Technology id="648">Intravenous formulation</Technology><Technology id="761">Biological therapeutic</Technology><Technology id="740">Infusion</Technology><Technology id="4">Immunoglobulin</Technology><Technology id="1651">Blood constituents</Technology></Technologies><LastModificationDate>2013-09-24T17:30:37.000Z</LastModificationDate><ChangeDateLast>2013-09-24T00:00:00.000Z</ChangeDateLast><AddedDate>2013-04-29T00:00:00.000Z</AddedDate><DevelopmentProfile><Summary><displayLabel>Summary</displayLabel><value>&lt;Summary&gt;&lt;para&gt;&lt;ulink linkType="Company" linkID="1079335"&gt;Guangdong Weilun Biological Products&lt;/ulink&gt; has developed and launched a freeze-dried, plasma-derived, intravenous   human immunoglobulin (pH4),   for the treatment of primary and secondary immunoglobulin G deficiency and autoimmune diseases (including thrombocytopenic purpura and Kawasaki disease). It was assumed that the product was launched in China shortly after its approval there in 1999 [&lt;ulink linkType="Reference" linkID="1411224"&gt;1411224&lt;/ulink&gt;], [&lt;ulink linkType="Reference" linkID="1411222"&gt;1411222&lt;/ulink&gt;].&lt;/para&gt;&lt;/Summary&gt;</value></Summary></DevelopmentProfile><IDdbDevelopmentStatus><DevelopmentStatusCurrent><Company id="1079335">Guangdong Weilun Biological Products Co Ltd</Company><Country id="CN">China</Country><DevelopmentStatus id="L" sortOrder="15">Launched</DevelopmentStatus><Indication id="2511">Immunoglobulin G deficiency</Indication><StatusDate>1999-12-31T00:00:00.000Z</StatusDate><Source id="1411222" type="CORPORATE"/></DevelopmentStatusCurrent><DevelopmentStatusCurrent><Company id="1079335">Guangdong Weilun Biological Products Co Ltd</Company><Country id="CN">China</Country><DevelopmentStatus id="L" sortOrder="15">Launched</DevelopmentStatus><Indication id="36">Autoimmune disease</Indication><StatusDate>1999-12-31T00:00:00.000Z</StatusDate><Source id="1411222" type="CORPORATE"/></DevelopmentStatusCurrent><DevelopmentStatusCurrent><Company id="1079335">Guangdong Weilun Biological Products Co Ltd</Company><Country id="CN">China</Country><DevelopmentStatus id="L" sortOrder="15">Launched</DevelopmentStatus><Indication id="1133">Thrombocytopenic purpura</Indication><StatusDate>1999-12-31T00:00:00.000Z</StatusDate><Source id="1411222" type="CORPORATE"/></DevelopmentStatusCurrent><DevelopmentStatusCurrent><Company id="1079335">Guangdong Weilun Biological Products Co Ltd</Company><Country id="CN">China</Country><DevelopmentStatus id="L" sortOrder="15">Launched</DevelopmentStatus><Indication id="780">Kawasaki disease</Indication><StatusDate>1999-12-31T00:00:00.000Z</StatusDate><Source id="1411222" type="CORPORATE"/></DevelopmentStatusCurrent><DevelopmentStatusHistoric><Company id="1079335">Guangdong Weilun Biological Products Co Ltd</Company><Country id="CN">China</Country><DevelopmentStatus id="R" sortOrder="14">Registered</DevelopmentStatus><Indication id="2511">Immunoglobulin G deficiency</Indication><StatusDate>1999-12-31T00:00:00.000Z</StatusDate><Source id="1411224" type="OTHER"/></DevelopmentStatusHistoric><DevelopmentStatusHistoric><Company id="1079335">Guangdong Weilun Biological Products Co Ltd</Company><Country id="CN">China</Country><DevelopmentStatus id="R" sortOrder="14">Registered</DevelopmentStatus><Indication id="36">Autoimmune disease</Indication><StatusDate>1999-12-31T00:00:00.000Z</StatusDate><Source id="1411224" type="OTHER"/></DevelopmentStatusHistoric><DevelopmentStatusHistoric><Company id="1079335">Guangdong Weilun Biological Products Co Ltd</Company><Country id="CN">China</Country><DevelopmentStatus id="R" sortOrder="14">Registered</DevelopmentStatus><Indication id="1133">Thrombocytopenic purpura</Indication><StatusDate>1999-12-31T00:00:00.000Z</StatusDate><Source id="1411224" type="OTHER"/></DevelopmentStatusHistoric><DevelopmentStatusHistoric><Company id="1079335">Guangdong Weilun Biological Products Co Ltd</Company><Country id="CN">China</Country><DevelopmentStatus id="R" sortOrder="14">Registered</DevelopmentStatus><Indication id="780">Kawasaki disease</Indication><StatusDate>1999-12-31T00:00:00.000Z</StatusDate><Source id="1411224" type="OTHER"/></DevelopmentStatusHistoric></IDdbDevelopmentStatus><Targets><Target id="PTGT-01004"><Name>Immunoglobulin</Name><SwissprotNumbers/></Target></Targets><ReasonsForUpdate><ReasonForUpdate><Reason>Development Status Updated</Reason><Description>One or more development status entries have been updated</Description></ReasonForUpdate><ReasonForUpdate><Reason>Indexing Updated</Reason><Description>Indexing updated</Description></ReasonForUpdate></ReasonsForUpdate><hasSWOTs>N</hasSWOTs></Drug></drugRecordsOutput>